3. Blood transfusion is a life
saving procedure and is of
immense importance.
Sometimes due to different
factors a reaction can
occur which can have
adverse effect on the
patient.
The objective of this
presentation is to know
different types of
transfusion reactions and
learn their management.
7. Stop the transfusion immediately
Check & Monitor vitals
Maintain IV access
Notify Lab for error
Check right pack has been transfused
Obtain CBC report & CXR post-reaction
8. Most common
Occurs during or in 24hrs of transfusion
Caused by Ab. against donor HLA antigens &
leucocytes
DIAGNOSIS OF EXCLUSION: Fever may be the
only symptom and may show a delayed
reaction!!
9. SYMPTOMS:
FEVER
DYSPNOEA
Consider and exclude other causes, as fever
alone may be the first manifestation of a life
threatening reaction.
INVESTIGATIONS:
Clinically assess for Rigors & Chills
Repeat ABO compatibility
Exclude hemolytic reaction
Investigate for sepsis
10. Treat the fever with an antipyretic.
Avoid aspirin in thrombocytopenic and
paediatric patients.
Follow general management for the reaction.
11. Medical Emergency!!
Transfused red cells are destroyed, due to
incompatibility of antigen on transfused cells
with antibody in the recipient circulation.
Occurs in 24 hrs of transfusion or during
transfusion.
Mostly caused due to human error.
12. Signs & Symptoms:
Haemolysis
Haemoglobinuria
Back pain
Fever
ARF
DIC
INVESTIGATIONS:
Clinically assess patient
Check clerical records for error
DAT, IAT
RFTs, Serum.Haptoglobulin
Repeat ABO and screening
13. MANAGEMENT:
Stop transfusion immediately and follow
other steps for managing suspected
transfusion reactions.
Seek urgent medical assistance.
Maintain blood pressure and renal output.
Induce diuresis with intravenous fluids and
diuretics.
This may become a medical emergency so
support blood pressure and maintain an open
airway.
Do not administer additional blood packs
until cleared by haematologist or Transfusion
Service Provider.
14. Generally occurs 2-10 days after transfusion.
One way this can occur is if a person without
a Kidd blood antigen receives a Kidd antigen
in a transfusion.
DEFINITION:It is defined as fever and other
symptoms/ signs of hemolysis more than 24
hours after transfusion.
15. CRITERIA:
Fall in Hb or failure to rise post-transfusion.
Rise in billrubin (jaundice)
In-compatible crossmatch not pre detectable.
Can occur upto 4 weeks after transfusion.
CLINICAL PICTURE:
Falling Hb
Hyprbillirubinemia
Spherocytes on peripheral smear
Low grade fever
16. Extremely Rare.
Occurs in Immunocompromised
individuals with identical HLA haplotypes.
Donor lymphocytes are engrafted by the
recipient which attack the recipient’s
tissues considering them foreign.
TA-GvHD can develop four to thirty days
after the transfusion.
Bone marrow Aplasia is common cause of
death.
17. CLINICAL PRESENTATION:
Skin: Erythroderma, Swollen, Bullae
formation(most common)
GIT: Diarrhoea, Abdominal cramps
LIVER: Elevated LFTs, Hyperbillirubinemia
HEME: Bone marrow aplasia, Thrombocytopenia
persistent
Only supportive treatment is given in GVHD. It
can be prevented by giving Gamma-irradiated
blood to those at risk.
18. Occurs during or 6hrs after transfusion.
Can cause ARDS
Can cause Non-Cardiogenic Pulmonary
edema
It is explained by 2-Hit hypothesis
All bllood products can cause it
19.
20. 2-HIT HYPOTHESIS:
1st hit is pulmonary pathology causing
localisation of neutrophils
2nd hit is transfusion of blood products with
sensitized neutrophils
CLINICAL PRESENTATION:
Hypoxemia (acute respiratory distress)
Fever
Tachycardia
Tachypnoea
21. CXR shows bilateral pulmonary infiltrates with
normal cardiac size.
CRITERIA OF DIAGNOSIS:
No acute injury prior to transfusion
No relation to risk factor for lung injury
Bilateral pulmonary infiltrates on CXR
No circulatory overload, PA
pressure<18mmhg
Oxygen saturation<90%
22.
23. MANAGEMENT:
Follow General Guidelines
Supportive therapy
Diurectics has no role and can worsen the
condition
Majority of patients may require mechanical
ventilation
Notify Blood Bank for the error
Editor's Notes
No treatment is given in absence of rapid hemolysis. Avoid offending agent in future.
Diagnosis is made on skin biopsy and occasionally on liver & bone marrow biopsy.
Immunocompromised, those receiving blood from family, leucoreduction filters can prevent but are not documented.
Use of male plasma has been shown to reduce the risk of TRALI as females contain more anti-HLA & anti-neutrophil antibodies.